medcitynews.com
Open in
urlscan Pro
2606:4700:20::681a:350
Public Scan
Submitted URL: https://info.medcitynews.com/e3t/Ctc/GA+113/cfk9H04/VWrFjX7xMLJDVHz09q7lSPmfW3NdgT55bfBp_N2F3N3C3lYMRW8wLKSR6lZ3nVN5dzzkKPj7Y...
Effective URL: https://medcitynews.com/2024/03/astrazeneca-lawsuit-medicare-drug-price-negotiation-farxiga/?utm_medium=email&_hsmi=2966...
Submission: On March 11 via manual from US — Scanned from DE
Effective URL: https://medcitynews.com/2024/03/astrazeneca-lawsuit-medicare-drug-price-negotiation-farxiga/?utm_medium=email&_hsmi=2966...
Submission: On March 11 via manual from US — Scanned from DE
Form analysis 6 forms found in the DOM
GET https://medcitynews.com/
<form method="get" class="search" action="https://medcitynews.com/" role="search">
<input type="text" class="field" name="s" value="" id="s" placeholder="Search …">
<button type="submit"><i class="fa fa-search"></i></button>
</form>GET https://medcitynews.com/
<form method="get" class="search" action="https://medcitynews.com/" role="search">
<input type="text" class="field" name="s" value="" id="s" placeholder="Search …">
<button type="submit"><i class="fa fa-search"></i></button>
</form>POST https://forms.hsforms.com/submissions/v3/public/submit/formsnext/multipart/2097126/a93d8b4e-029d-4de9-9599-c09510e52983
<form id="hsForm_a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-mobile-interstitial" method="POST" accept-charset="UTF-8" enctype="multipart/form-data" novalidate=""
action="https://forms.hsforms.com/submissions/v3/public/submit/formsnext/multipart/2097126/a93d8b4e-029d-4de9-9599-c09510e52983"
class="hs-form-private hsForm_a93d8b4e-029d-4de9-9599-c09510e52983 hs-form-a93d8b4e-029d-4de9-9599-c09510e52983 hs-form-a93d8b4e-029d-4de9-9599-c09510e52983_ead2e909-95fc-4451-8028-e30ff61340b4 hs-form stacked hs-custom-style"
target="target_iframe_a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-mobile-interstitial" data-instance-id="ead2e909-95fc-4451-8028-e30ff61340b4" data-form-id="a93d8b4e-029d-4de9-9599-c09510e52983"
data-portal-id="2097126" data-test-id="hsForm_a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-mobile-interstitial">
<div class="hs_email hs-email hs-fieldtype-text field hs-form-field"><label id="label-email-a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-mobile-interstitial" class="" placeholder="Enter your "
for="email-a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-mobile-interstitial"><span></span></label>
<legend class="hs-field-desc" style="display: none;"></legend>
<div class="input"><input id="email-a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-mobile-interstitial" name="email" required="" placeholder="Your email address*" type="email" class="hs-input" inputmode="email"
autocomplete="email" value=""></div>
</div>
<div class="hs_submit hs-submit">
<div class="hs-field-desc" style="display: none;"></div>
<div class="actions"><input type="submit" class="hs-button primary large" value="Sign Up Now"></div>
</div><input name="hs_context" type="hidden"
value="{"embedAtTimestamp":"1710169490757","formDefinitionUpdatedAt":"1704291213489","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36","pageTitle":"AstraZeneca Loses Lawsuit Challenging Drug Price Negotiation by Medicare - MedCity News","pageUrl":"https://medcitynews.com/2024/03/astrazeneca-lawsuit-medicare-drug-price-negotiation-farxiga/?utm_medium=email&_hsmi=296688212&_hsenc=p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A&utm_content=296688212&utm_source=hs_email","urlParams":{"utm_medium":"email","_hsmi":"296688212","_hsenc":"p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A","utm_content":"296688212","utm_source":"hs_email"},"isHubSpotCmsGeneratedPage":false,"hutk":"4c457a18ef75c7f125201d3ef2e89c2d","__hsfp":166860084,"__hssc":"230869696.1.1710169507138","__hstc":"230869696.4c457a18ef75c7f125201d3ef2e89c2d.1710169507138.1710169507138.1710169507138.1","formTarget":"#newsletter-form-mobile-interstitial","formInstanceId":"a93d8b4e-029d-4de9-9599-c09510e52983-mobile-interstitial","rumScriptExecuteTime":1720.5,"rumTotalRequestTime":17792,"rumTotalRenderTime":17856.89999961853,"rumServiceResponseTime":16071.5,"rumFormRenderTime":64.89999961853027,"connectionType":"4g","firstContentfulPaint":0,"largestContentfulPaint":0,"locale":"en","timestamp":1710169507146,"originalEmbedContext":{"portalId":"2097126","formId":"a93d8b4e-029d-4de9-9599-c09510e52983","region":"na1","target":"#newsletter-form-mobile-interstitial","isBuilder":false,"isTestPage":false,"isPreview":false,"formInstanceId":"a93d8b4e-029d-4de9-9599-c09510e52983-mobile-interstitial","isMobileResponsive":true},"correlationId":"ead2e909-95fc-4451-8028-e30ff61340b4","renderedFieldsIds":["email"],"captchaStatus":"NOT_APPLICABLE","emailResubscribeStatus":"NOT_APPLICABLE","isInsideCrossOriginFrame":false,"source":"forms-embed-1.4774","sourceName":"forms-embed","sourceVersion":"1.4774","sourceVersionMajor":"1","sourceVersionMinor":"4774","allPageIds":{},"_debug_embedLogLines":[{"clientTimestamp":1710169506596,"level":"INFO","message":"Retrieved customer callbacks used on embed context: [\"onFormSubmit\"]"},{"clientTimestamp":1710169506596,"level":"INFO","message":"Retrieved pageContext values which may be overriden by the embed context: {\"pageTitle\":\"AstraZeneca Loses Lawsuit Challenging Drug Price Negotiation by Medicare - MedCity News\",\"pageUrl\":\"https://medcitynews.com/2024/03/astrazeneca-lawsuit-medicare-drug-price-negotiation-farxiga/?utm_medium=email&_hsmi=296688212&_hsenc=p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A&utm_content=296688212&utm_source=hs_email\",\"userAgent\":\"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36\",\"urlParams\":{\"utm_medium\":\"email\",\"_hsmi\":\"296688212\",\"_hsenc\":\"p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A\",\"utm_content\":\"296688212\",\"utm_source\":\"hs_email\"},\"isHubSpotCmsGeneratedPage\":false}"},{"clientTimestamp":1710169506598,"level":"INFO","message":"Retrieved countryCode property from normalized embed definition response: \"DE\""},{"clientTimestamp":1710169507144,"level":"INFO","message":"Retrieved analytics values from API response which may be overriden by the embed context: {\"hutk\":\"4c457a18ef75c7f125201d3ef2e89c2d\"}"}]}"><iframe
name="target_iframe_a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-mobile-interstitial" style="display: none;"></iframe>
</form>POST https://forms.hsforms.com/submissions/v3/public/submit/formsnext/multipart/2097126/a93d8b4e-029d-4de9-9599-c09510e52983
<form id="hsForm_a93d8b4e-029d-4de9-9599-c09510e52983" method="POST" accept-charset="UTF-8" enctype="multipart/form-data" novalidate=""
action="https://forms.hsforms.com/submissions/v3/public/submit/formsnext/multipart/2097126/a93d8b4e-029d-4de9-9599-c09510e52983"
class="hs-form-private hsForm_a93d8b4e-029d-4de9-9599-c09510e52983 hs-form-a93d8b4e-029d-4de9-9599-c09510e52983 hs-form-a93d8b4e-029d-4de9-9599-c09510e52983_d9d18556-7796-44a7-a092-ecb7154a40c6 hs-form stacked hs-custom-style"
target="target_iframe_a93d8b4e-029d-4de9-9599-c09510e52983" data-instance-id="d9d18556-7796-44a7-a092-ecb7154a40c6" data-form-id="a93d8b4e-029d-4de9-9599-c09510e52983" data-portal-id="2097126"
data-test-id="hsForm_a93d8b4e-029d-4de9-9599-c09510e52983">
<div class="hs_email hs-email hs-fieldtype-text field hs-form-field"><label id="label-email-a93d8b4e-029d-4de9-9599-c09510e52983" class="" placeholder="Enter your " for="email-a93d8b4e-029d-4de9-9599-c09510e52983"><span></span></label>
<legend class="hs-field-desc" style="display: none;"></legend>
<div class="input"><input id="email-a93d8b4e-029d-4de9-9599-c09510e52983" name="email" required="" placeholder="Your email address*" type="email" class="hs-input" inputmode="email" autocomplete="email" value=""></div>
</div>
<div class="hs_submit hs-submit">
<div class="hs-field-desc" style="display: none;"></div>
<div class="actions"><input type="submit" class="hs-button primary large" value="Sign Up Now"></div>
</div><input name="hs_context" type="hidden"
value="{"embedAtTimestamp":"1710169506722","formDefinitionUpdatedAt":"1704291213489","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36","pageTitle":"AstraZeneca Loses Lawsuit Challenging Drug Price Negotiation by Medicare - MedCity News","pageUrl":"https://medcitynews.com/2024/03/astrazeneca-lawsuit-medicare-drug-price-negotiation-farxiga/?utm_medium=email&_hsmi=296688212&_hsenc=p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A&utm_content=296688212&utm_source=hs_email","urlParams":{"utm_medium":"email","_hsmi":"296688212","_hsenc":"p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A","utm_content":"296688212","utm_source":"hs_email"},"isHubSpotCmsGeneratedPage":false,"hutk":"4c457a18ef75c7f125201d3ef2e89c2d","__hsfp":166860084,"__hssc":"230869696.1.1710169507138","__hstc":"230869696.4c457a18ef75c7f125201d3ef2e89c2d.1710169507138.1710169507138.1710169507138.1","formTarget":"#signup-main-hubspot","rumScriptExecuteTime":1782.6999988555908,"rumTotalRequestTime":17981.19999885559,"rumTotalRenderTime":17986.39999961853,"rumServiceResponseTime":16198.5,"rumFormRenderTime":5.200000762939453,"connectionType":"4g","firstContentfulPaint":0,"largestContentfulPaint":0,"locale":"en","timestamp":1710169507152,"originalEmbedContext":{"portalId":"2097126","formId":"a93d8b4e-029d-4de9-9599-c09510e52983","region":"na1","target":"#signup-main-hubspot","isBuilder":false,"isTestPage":false,"isPreview":false,"css":"","redirectUrl":"http://medcitynews.com/youre-subscribed/","isMobileResponsive":true},"correlationId":"d9d18556-7796-44a7-a092-ecb7154a40c6","renderedFieldsIds":["email"],"captchaStatus":"NOT_APPLICABLE","emailResubscribeStatus":"NOT_APPLICABLE","isInsideCrossOriginFrame":false,"source":"forms-embed-1.4774","sourceName":"forms-embed","sourceVersion":"1.4774","sourceVersionMajor":"1","sourceVersionMinor":"4774","allPageIds":{},"_debug_embedLogLines":[{"clientTimestamp":1710169506786,"level":"INFO","message":"Retrieved customer callbacks used on embed context: [\"onFormSubmit\"]"},{"clientTimestamp":1710169506787,"level":"INFO","message":"Retrieved pageContext values which may be overriden by the embed context: {\"pageTitle\":\"AstraZeneca Loses Lawsuit Challenging Drug Price Negotiation by Medicare - MedCity News\",\"pageUrl\":\"https://medcitynews.com/2024/03/astrazeneca-lawsuit-medicare-drug-price-negotiation-farxiga/?utm_medium=email&_hsmi=296688212&_hsenc=p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A&utm_content=296688212&utm_source=hs_email\",\"userAgent\":\"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36\",\"urlParams\":{\"utm_medium\":\"email\",\"_hsmi\":\"296688212\",\"_hsenc\":\"p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A\",\"utm_content\":\"296688212\",\"utm_source\":\"hs_email\"},\"isHubSpotCmsGeneratedPage\":false}"},{"clientTimestamp":1710169506787,"level":"INFO","message":"Retrieved countryCode property from normalized embed definition response: \"DE\""},{"clientTimestamp":1710169507151,"level":"INFO","message":"Retrieved analytics values from API response which may be overriden by the embed context: {\"hutk\":\"4c457a18ef75c7f125201d3ef2e89c2d\"}"}]}"><iframe
name="target_iframe_a93d8b4e-029d-4de9-9599-c09510e52983" style="display: none;"></iframe>
</form>POST https://forms.hsforms.com/submissions/v3/public/submit/formsnext/multipart/2097126/a93d8b4e-029d-4de9-9599-c09510e52983
<form id="hsForm_a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-sidebar" method="POST" accept-charset="UTF-8" enctype="multipart/form-data" novalidate=""
action="https://forms.hsforms.com/submissions/v3/public/submit/formsnext/multipart/2097126/a93d8b4e-029d-4de9-9599-c09510e52983"
class="hs-form-private hsForm_a93d8b4e-029d-4de9-9599-c09510e52983 hs-form-a93d8b4e-029d-4de9-9599-c09510e52983 hs-form-a93d8b4e-029d-4de9-9599-c09510e52983_9b856426-f7f4-4435-88f8-059418f3dd9a hs-form stacked hs-custom-style"
target="target_iframe_a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-sidebar" data-instance-id="9b856426-f7f4-4435-88f8-059418f3dd9a" data-form-id="a93d8b4e-029d-4de9-9599-c09510e52983" data-portal-id="2097126"
data-test-id="hsForm_a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-sidebar">
<div class="hs_email hs-email hs-fieldtype-text field hs-form-field"><label id="label-email-a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-sidebar" class="" placeholder="Enter your "
for="email-a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-sidebar"><span></span></label>
<legend class="hs-field-desc" style="display: none;"></legend>
<div class="input"><input id="email-a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-sidebar" name="email" required="" placeholder="Your email address*" type="email" class="hs-input" inputmode="email" autocomplete="email"
value=""></div>
</div>
<div class="hs_submit hs-submit">
<div class="hs-field-desc" style="display: none;"></div>
<div class="actions"><input type="submit" class="hs-button primary large" value="Sign Up Now"></div>
</div><input name="hs_context" type="hidden"
value="{"embedAtTimestamp":"1710169490792","formDefinitionUpdatedAt":"1704291213489","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36","pageTitle":"AstraZeneca Loses Lawsuit Challenging Drug Price Negotiation by Medicare - MedCity News","pageUrl":"https://medcitynews.com/2024/03/astrazeneca-lawsuit-medicare-drug-price-negotiation-farxiga/?utm_medium=email&_hsmi=296688212&_hsenc=p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A&utm_content=296688212&utm_source=hs_email","urlParams":{"utm_medium":"email","_hsmi":"296688212","_hsenc":"p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A","utm_content":"296688212","utm_source":"hs_email"},"isHubSpotCmsGeneratedPage":false,"hutk":"4c457a18ef75c7f125201d3ef2e89c2d","__hsfp":166860084,"__hssc":"230869696.1.1710169507138","__hstc":"230869696.4c457a18ef75c7f125201d3ef2e89c2d.1710169507138.1710169507138.1710169507138.1","formTarget":"#newsletter-form-sidebar","formInstanceId":"a93d8b4e-029d-4de9-9599-c09510e52983-sidebar","rumScriptExecuteTime":1782.6999988555908,"rumTotalRequestTime":17801.39999961853,"rumTotalRenderTime":17859.19999885559,"rumServiceResponseTime":16018.70000076294,"rumFormRenderTime":57.79999923706055,"connectionType":"4g","firstContentfulPaint":0,"largestContentfulPaint":0,"locale":"en","timestamp":1710169507148,"originalEmbedContext":{"portalId":"2097126","formId":"a93d8b4e-029d-4de9-9599-c09510e52983","region":"na1","target":"#newsletter-form-sidebar","isBuilder":false,"isTestPage":false,"isPreview":false,"formInstanceId":"a93d8b4e-029d-4de9-9599-c09510e52983-sidebar","isMobileResponsive":true},"correlationId":"9b856426-f7f4-4435-88f8-059418f3dd9a","renderedFieldsIds":["email"],"captchaStatus":"NOT_APPLICABLE","emailResubscribeStatus":"NOT_APPLICABLE","isInsideCrossOriginFrame":false,"source":"forms-embed-1.4774","sourceName":"forms-embed","sourceVersion":"1.4774","sourceVersionMajor":"1","sourceVersionMinor":"4774","allPageIds":{},"_debug_embedLogLines":[{"clientTimestamp":1710169506606,"level":"INFO","message":"Retrieved customer callbacks used on embed context: [\"onFormSubmit\"]"},{"clientTimestamp":1710169506606,"level":"INFO","message":"Retrieved pageContext values which may be overriden by the embed context: {\"pageTitle\":\"AstraZeneca Loses Lawsuit Challenging Drug Price Negotiation by Medicare - MedCity News\",\"pageUrl\":\"https://medcitynews.com/2024/03/astrazeneca-lawsuit-medicare-drug-price-negotiation-farxiga/?utm_medium=email&_hsmi=296688212&_hsenc=p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A&utm_content=296688212&utm_source=hs_email\",\"userAgent\":\"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36\",\"urlParams\":{\"utm_medium\":\"email\",\"_hsmi\":\"296688212\",\"_hsenc\":\"p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A\",\"utm_content\":\"296688212\",\"utm_source\":\"hs_email\"},\"isHubSpotCmsGeneratedPage\":false}"},{"clientTimestamp":1710169506607,"level":"INFO","message":"Retrieved countryCode property from normalized embed definition response: \"DE\""},{"clientTimestamp":1710169507146,"level":"INFO","message":"Retrieved analytics values from API response which may be overriden by the embed context: {\"hutk\":\"4c457a18ef75c7f125201d3ef2e89c2d\"}"}]}"><iframe
name="target_iframe_a93d8b4e-029d-4de9-9599-c09510e52983_a93d8b4e-029d-4de9-9599-c09510e52983-sidebar" style="display: none;"></iframe>
</form>POST https://forms.hsforms.com/submissions/v3/public/submit/formsnext/multipart/2097126/30083c7c-72db-412b-8a6e-e72e5b9308ce
<form id="hsForm_30083c7c-72db-412b-8a6e-e72e5b9308ce" method="POST" accept-charset="UTF-8" enctype="multipart/form-data" novalidate=""
action="https://forms.hsforms.com/submissions/v3/public/submit/formsnext/multipart/2097126/30083c7c-72db-412b-8a6e-e72e5b9308ce"
class="hs-form-private hsForm_30083c7c-72db-412b-8a6e-e72e5b9308ce hs-form-30083c7c-72db-412b-8a6e-e72e5b9308ce hs-form-30083c7c-72db-412b-8a6e-e72e5b9308ce_a51ad216-b006-4aef-a7fd-5e6490cb59bd hs-form stacked"
target="target_iframe_30083c7c-72db-412b-8a6e-e72e5b9308ce" data-instance-id="a51ad216-b006-4aef-a7fd-5e6490cb59bd" data-form-id="30083c7c-72db-412b-8a6e-e72e5b9308ce" data-portal-id="2097126"
data-test-id="hsForm_30083c7c-72db-412b-8a6e-e72e5b9308ce">
<div class="hs_email hs-email hs-fieldtype-text field hs-form-field"><label id="label-email-30083c7c-72db-412b-8a6e-e72e5b9308ce" class="" placeholder="Enter your " for="email-30083c7c-72db-412b-8a6e-e72e5b9308ce"><span></span></label>
<legend class="hs-field-desc" style="display: none;"></legend>
<div class="input"><input id="email-30083c7c-72db-412b-8a6e-e72e5b9308ce" name="email" required="" placeholder="Your email address*" type="email" class="hs-input" inputmode="email" autocomplete="email" value=""></div>
</div>
<div class="hs_submit hs-submit">
<div class="hs-field-desc" style="display: none;"></div>
<div class="actions"><input type="submit" class="hs-button primary large" value="Subscribe"></div>
</div><input name="hs_context" type="hidden"
value="{"embedAtTimestamp":"1710169506743","formDefinitionUpdatedAt":"1632778230100","userAgent":"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36","pageTitle":"AstraZeneca Loses Lawsuit Challenging Drug Price Negotiation by Medicare - MedCity News","pageUrl":"https://medcitynews.com/2024/03/astrazeneca-lawsuit-medicare-drug-price-negotiation-farxiga/?utm_medium=email&_hsmi=296688212&_hsenc=p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A&utm_content=296688212&utm_source=hs_email","urlParams":{"utm_medium":"email","_hsmi":"296688212","_hsenc":"p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A","utm_content":"296688212","utm_source":"hs_email"},"isHubSpotCmsGeneratedPage":false,"hutk":"4c457a18ef75c7f125201d3ef2e89c2d","__hsfp":166860084,"__hssc":"230869696.1.1710169507138","__hstc":"230869696.4c457a18ef75c7f125201d3ef2e89c2d.1710169507138.1710169507138.1710169507138.1","formTarget":"#interstitial_hubspot","rumScriptExecuteTime":1782.6999988555908,"rumTotalRequestTime":18025.19999885559,"rumTotalRenderTime":18029.39999961853,"rumServiceResponseTime":16242.5,"rumFormRenderTime":4.200000762939453,"connectionType":"4g","firstContentfulPaint":0,"largestContentfulPaint":0,"locale":"en","timestamp":1710169507153,"originalEmbedContext":{"portalId":"2097126","formId":"30083c7c-72db-412b-8a6e-e72e5b9308ce","region":"na1","target":"#interstitial_hubspot","isBuilder":false,"isTestPage":false,"isPreview":false,"css":"","redirectUrl":"http://medcitynews.com/youre-subscribed/","isMobileResponsive":true},"correlationId":"a51ad216-b006-4aef-a7fd-5e6490cb59bd","renderedFieldsIds":["email"],"captchaStatus":"NOT_APPLICABLE","emailResubscribeStatus":"NOT_APPLICABLE","isInsideCrossOriginFrame":false,"source":"forms-embed-1.4774","sourceName":"forms-embed","sourceVersion":"1.4774","sourceVersionMajor":"1","sourceVersionMinor":"4774","allPageIds":{},"_debug_embedLogLines":[{"clientTimestamp":1710169506830,"level":"INFO","message":"Retrieved customer callbacks used on embed context: [\"onFormReady\",\"onFormSubmit\"]"},{"clientTimestamp":1710169506830,"level":"INFO","message":"Retrieved pageContext values which may be overriden by the embed context: {\"pageTitle\":\"AstraZeneca Loses Lawsuit Challenging Drug Price Negotiation by Medicare - MedCity News\",\"pageUrl\":\"https://medcitynews.com/2024/03/astrazeneca-lawsuit-medicare-drug-price-negotiation-farxiga/?utm_medium=email&_hsmi=296688212&_hsenc=p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A&utm_content=296688212&utm_source=hs_email\",\"userAgent\":\"Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.111 Safari/537.36\",\"urlParams\":{\"utm_medium\":\"email\",\"_hsmi\":\"296688212\",\"_hsenc\":\"p2ANqtz--tU_qvWaCN9xpIXGVa35GoAoBMtRIeutTcxs9TzUEvtPqAm-b2OX1TPTSxM1kZBNM6BAqgxtiHbeBsLRVZAVMdQUae_A\",\"utm_content\":\"296688212\",\"utm_source\":\"hs_email\"},\"isHubSpotCmsGeneratedPage\":false}"},{"clientTimestamp":1710169506831,"level":"INFO","message":"Retrieved countryCode property from normalized embed definition response: \"DE\""},{"clientTimestamp":1710169507152,"level":"INFO","message":"Retrieved analytics values from API response which may be overriden by the embed context: {\"hutk\":\"4c457a18ef75c7f125201d3ef2e89c2d\"}"}]}"><iframe
name="target_iframe_30083c7c-72db-412b-8a6e-e72e5b9308ce" style="display: none;"></iframe>
</form>Text Content
Menu Search * Home * News * Health Tech * Biopharma * Devices & Diagnostics * Consumer / Employer * Contributors * MedCity Influencers * MedCitizens * Events * Podcasts * Research * Newsletters * About Us * Advertising * Contact us * Send Tips * Advertising * About * Twitter * Facebook * RSS * Subscribe via email X Close Signup Modal MEDCITY >> INBOX Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy. * Send Tips * Advertising * About * Twitter * Facebook * RSS * Subscribe via email MEDCITY NEWS COST PLUS DRUGS, TALKSPACE, HEALTH GORILLA JOIN WHEEL’S VIRTUAL CARE ECOSYSTEM HOW MARKETING FUELED THE OPIOID OVERDOSE CRISIS AND WHAT WE CAN LEARN FROM IT REVOLUTIONIZING REVENUE: UNLEASHING THE POWER OF AI IN DENIALS MANAGEMENT MOUNT SINAI CEO: HOSPITALS WILL START SEEING ROI FROM THEIR AI INVESTMENTS IN A COUPLE YEARS BLOCKBUSTER BEIGENE CANCER DRUG ADDS ANOTHER FDA APPROVAL 4 HEALTHCARE TAKEAWAYS FROM BIDEN’S STATE OF THE UNION ADDRESS HOW SHOULD PROVIDERS BE APPROACHING THE GENERATIVE AI FRENZY? DIGITAL THERAPEUTICS FIND OPPORTUNITY IN HEALTHCARE ECONOMICS OUTCOMES AFTER ALS DRUG FAILS IN PHASE 3, AMYLYX WEIGHS PULLING THE PRODUCT FROM MARKET REGISTER FOR MEDCITY INVEST WHERE STARTUPS AND INVESTORS CONNECT STARTUPDATES: NEW DEVELOPMENTS FROM HEALTHCARE STARTUPS BLUE SHIELD OF CALIFORNIA CEO ON PBM SHAKEUP: ‘IT’S GOING TO BECOME THE NORM’ ANSWERING 7 KEY QUESTIONS ABOUT CHANGE HEALTHCARE’S CYBERATTACK NOVO NORDISK OBESITY PILL FLASHES THE POTENTIAL TO BEAT WEGOVY IN WEIGHT LOSS SLEEP MEDS DON’T WORK FOR 9 OUT OF 10 PEOPLE WITH CHRONIC INSOMNIA – HERE’S WHAT DOES * News * Health Tech * BioPharma * Devices & Diagnostics * Consumer / Employer * Contributors * MedCity Influencers * MedCitizens * Events * INVEST * INVEST Digital Health * ENGAGE at HLTH * Podcasts * Research * Newsletters Pharma, BioPharma, Legal ASTRAZENECA LOSES LAWSUIT CHALLENGING DRUG PRICE NEGOTIATION BY MEDICARE A FEDERAL JUDGE DISAGREED WITH ASTRAZENECA’S CLAIMS THAT THE INFLATION REDUCTION ACT CAUSES HARM BY DISINCENTIVIZING INNOVATION AND VIOLATES ITS CONSTITUTIONAL RIGHTS TO DUE PROCESS. BLOCKBUSTER ASTRAZENECA DRUG FARXIGA IS ONE OF 10 MEDICATIONS SELECTED FOR THE MEDICARE DRUG PRICE NEGOTIATION PROGRAM CREATED BY THE LAW. By Frank Vinluan Post a comment / Mar 3, 2024 at 11:31 AM 0Shares AstraZeneca has lost its lawsuit challenging Medicare’s drug price negotiation program after a federal judge concluded the pharmaceutical giant has no standing to contest the law that created it, nor does the company have a constitutionally protected property interest in the matter. The decision Friday is the first issued for several lawsuits filed by pharmaceutical companies in opposition to certain provisions of the law, the Inflation Reduction Act (IRA). Many of them make constitutional claims similar to those argued by AstraZeneca. Promoted HOW CORTI’S AI SYSTEM ASSISTS CLINICIANS Andreas Cleve, Corti CEO, talks on how his company handles AI responsibly with its customers. Corti and MedCity News Farxiga, a blockbuster AstraZeneca medicine with approvals in type 2 diabetes, heart failure, and chronic kidney disease, is one of the first 10 drugs selected by CMS for negotiation. These drugs, which have no generic competition, represented more than $50 billion in Medicare Part D costs between June 1, 2022, and May 31, 2023. AstraZeneca claimed that CMS’s guidance placing Farxiga on the list of drugs is a violation of the federal Administrative Procedure Act. The company argued that this placement causes it harm by eliminating incentives for developing innovative new uses for the drug, which in turn will narrow patient access to new treatments. AstraZeneca also claimed the IRA is unconstitutional. Colm Connolly, chief judge for the U.S. District Court for the District of Delaware, questioned AstraZeneca’s position that it would be harmed. In the 45-page opinion, Connolly wrote that the loss or diminishment of an incentive to do something is not a concrete injury. The harm AstraZeneca claims is hypothetical and could happen if the company were to develop new formulations of new uses of Farxiga’s active pharmaceutical ingredient—but only if these new uses received FDA approval, and then only if the drug were selected for price negotiation. “The fact that the word ‘if’ is required to describe AstraZeneca’s alleged injury demonstrates that the harm it complains of is neither actual nor certainly impending,” Connolly said. Promoted IMPROVING COMMUNICATION BETWEEN PATIENTS AND PROVIDERS Sarah Shillington, Chief Customer Officer notes how Artera’s omnichannel platform works. Artera and MedCity News Furthermore, Connolly disagreed with AstraZeneca’s claim that the law violates its rights under the Fifth Amendment, which states that no one shall be “deprived of life, liberty, or property without due process of law.” Connolly said the expectation or desire to sell drugs at the higher prices a company once enjoyed does not create a protected property interest. No one is entitled to sell to the government at prices the government won’t pay, he said. “And because AstraZeneca has no legitimate claim of entitlement to sell its drugs to the government at any price other than what the Government is willing to pay, its due process claim fails as a matter of law,” Connolly wrote. In a statement sent to media outlets in response to the ruling, AstraZeneca said it is still assessing its options. “We are disappointed with the court’s decision and the potential negative impact it will have on patients’ access to future life-saving medicines,” the company said. “We believe our challenge is necessary to support and improve patients’ access to future life-saving medicines, and our rights as a company. There is a lot at stake here, and we are actively evaluating our path forward.” The case, filed in the U.S District Court for the District of Delaware, is AstraZeneca LP and AstraZeneca AB v. Xavier Becerra in his official capacity as secretary of Health and Human Services, and Chiquita Brooks-Lasure, in her official capacity as administrator of the Centers for Medicare and Medicaid Services. The case is number 1:23-cv-931-CFC. AstraZeneca’s lawsuit is one of eight filed by pharmaceutical companies that are challenging the IRA. Two suits from industry groups have also been filed. One of them was dismissed last month by a judge in the U.S. District Court for the Western District of Texas. The National Infusion Center—the only one of the three plaintiffs residing in Texas—was dismissed from the suit. Consequently, the case was dismissed due to improper venue. Photo: Christopher Furlong, Getty Images 0Shares This article is featured in the Healthcare Docket newsletter, a partnership between Breaking Media publications MedCity News and Above the Law. Enter your email address to subscribe. TOPICS AstraZeneca, Center for Medicare and Medicaid Services, Delaware, drug prices, farxiga, lawsuit HEAR THE LATEST INDUSTRY NEWS FIRST. SIGN UP FOR OUR DAILY NEWSLETTER. We will never sell or share your information without your consent. See our privacy policy. Promoted REMOVING PAIN POINTS AND IMPROVING ACCESS FOR RURAL HEALTHCARE SYSTEMS Chris Fowler, CEO of TruBridge talks about focusing on rural community healthcare. TruBridge and MedCity News SIGN UP TO RECEIVE OUR MEDCITY NEWS DAILY BRIEFING. We will never sell or share your information without your consent. See our privacy policy. Promoted HOW FIRST DOLLAR PROVIDES SUPPORT WITH HEALTHCARE BENEFITS CEO of First Dollar, Jason Bornhorst discusses how his company can assist with employee benefits. First Dollar and MedCity News × HEAR THE LATEST INDUSTRY NEWS FIRST. SIGN UP FOR OUR DAILY NEWSLETTER. No thanks We will never sell or share your information without your consent. See our privacy policy. Advertise About Newsletter Our Sites * * * * * * * © 2024 Breaking Media, Inc. All rights reserved. Registration or use of this site constitutes acceptance of our Terms of Service and Privacy Policy. 0Shares Share this Article Friend's Email Address Your Name Your Email Address Comments Send Email Email sent! By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Reject All Accept All Cookies PRIVACY PREFERENCE CENTER When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer. More information Allow All MANAGE CONSENT PREFERENCES FUNCTIONAL COOKIES Functional Cookies These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. PERFORMANCE COOKIES Performance Cookies These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. STRICTLY NECESSARY COOKIES Always Active These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. TARGETING COOKIES Targeting Cookies These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Back Button COOKIE LIST Search Icon Filter Icon Clear checkbox label label Apply Cancel Consent Leg.Interest checkbox label label checkbox label label checkbox label label Reject All Confirm My Choices